Regulation FDA’s Tissue Reference Group: Who Decides Whether a Tissue Product Is 361 or 351 Read More » Oscar Tellez 10/21/2026 10:00 AM
Regulation FDA’s 2026 Plausible Mechanism Draft Guidance: What It Could Mean for Autologous Cells Read More » Oscar Tellez 10/19/2026 10:00 AM
Regulation Tissue Recalls: How an HCT/P Recall Works and What It Would Mean for Banked Tissue Read More » Oscar Tellez 10/16/2026 10:00 AM
Regulation Which States License Tissue Banks, and Why It Matters for Your Banked Tissue Read More » Oscar Tellez 10/15/2026 10:00 AM
Regulation California Tissue Bank Licensing: What Health and Safety Code 1635 Requires Read More » Oscar Tellez 10/13/2026 10:00 AM
Regulation FDA Tissue Establishment Inspections: What Part 1271 Subpart F Lets FDA Do Read More » Oscar Tellez 10/12/2026 10:00 AM
Regulation Montana’s Experimental Treatment Center Law: What SB 535 (2025) Set Up Read More » Oscar Tellez 10/08/2026 10:00 AM
Regulation New York Tissue Bank Licensing: Why Article 43-B Matters for Banked Tissue Read More » Oscar Tellez 10/07/2026 10:00 AM
Regulation The Cell Surgical Network Injunction: What the August 2026 Ruling on Fat-Derived SVF Means for Banked Tissue Read More » Oscar Tellez 10/05/2026 10:00 AM
Regulation AATB Accreditation: What the 15th Edition Standards Cover, How to Check a Bank, and What Changes January 31, 2027 Read More » Oscar Tellez 10/01/2026 10:00 AM